These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 16841563)
1. [Clinical observations with aripiprazole in schizophrenia]. Gaszner P Neuropsychopharmacol Hung; 2006 Mar; 8(1):29-32. PubMed ID: 16841563 [TBL] [Abstract][Full Text] [Related]
2. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient. Kuo J; Hwu HG Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984 [TBL] [Abstract][Full Text] [Related]
3. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist. Burke MJ; Lincoln J Ann Clin Psychiatry; 2006; 18(2):129-30. PubMed ID: 16754419 [No Abstract] [Full Text] [Related]
4. Aripiprazole: new drug. Just another neuroleptic. Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069 [TBL] [Abstract][Full Text] [Related]
5. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982 [TBL] [Abstract][Full Text] [Related]
6. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A; J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849 [TBL] [Abstract][Full Text] [Related]
7. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E; Tourjman V Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550 [TBL] [Abstract][Full Text] [Related]
9. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Naber D; Lambert M Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748 [TBL] [Abstract][Full Text] [Related]
10. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole: a review of its pharmacology and clinical use. Taylor DM Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943 [TBL] [Abstract][Full Text] [Related]
12. An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being. Liemburg E; Aleman A; Bous J; Hollander K; Knegtering H Pharmacopsychiatry; 2011 May; 44(3):109-13. PubMed ID: 21432752 [TBL] [Abstract][Full Text] [Related]
13. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine. Mossaheb N; Spindelegger C; Asenbaum S; Fischer P; Barnas C World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):502-5. PubMed ID: 20218805 [TBL] [Abstract][Full Text] [Related]
14. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824 [TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in schizophrenia: consensus guidelines. Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869 [TBL] [Abstract][Full Text] [Related]
16. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981 [TBL] [Abstract][Full Text] [Related]
17. Trial of aripiprazole in the treatment of first-episode schizophrenia. Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024 [TBL] [Abstract][Full Text] [Related]
18. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole. Huang WL; Chang LR Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252 [No Abstract] [Full Text] [Related]
19. Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors. Chen SF; Shen YC; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):470-4. PubMed ID: 19302829 [TBL] [Abstract][Full Text] [Related]
20. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients. Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]